Genetics and public health - Evolution, or revolution?

Journal of Epidemiology and Community Health

Volumn 58, Issue 11, 2004, Pages 894-899

  Halliday, Jane L ^a,b   Collins, Veronica R ^a,b   Aitken, Mary Anne ^a,b   Richards, Martin P M ^c   Olsson, Craig A ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; GENETICS; HEALTH CARE; PUBLIC HEALTH;

CANCER; EDUCATION; GENETICS; HEALTH PROMOTION; HEART DISEASE; HUMAN RIGHTS; MEDICAL GENETICS; PUBLIC HEALTH; REVIEW; RISK FACTOR;

GENETICS AND REPRODUCTION; HEALTH CARE AND PUBLIC HEALTH;

ATTITUDE TO HEALTH; EUGENICS; GENETIC PREDISPOSITION TO DISEASE; GENETICS, MEDICAL; HUMANS; INTERPROFESSIONAL RELATIONS; PUBLIC HEALTH;

EID: 7044252988     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2003.018515     Document Type: Review

References (115)

1. Collins FS, McKusick VA. Implications of the Human Genome Project for medical science. JAMA 2001;285:540-4.
2. Bell J. The new genetics in clinical practice. BMJ 1998;316:618-20.
3. van Ommen GJB, Bakker E, den Dunnen JT. The human genome project and the future of diagnostics, treatment and prevention. Lancet 1999;354(suppl 1):5-19.
4. Radda G, Dexter TM, Meade T. The need for independent scientific peer review of Biobank UK. Reply from Biobank UK. Lancet 2002;359:2282.
5. Abbott A. With your genes? Take one of these, three times a day. Nature 2003;425:760-2.
6. Buchonon A, Brock DW, Daniels N, et al. From chance to choice: genetics and justice. Cambridge: Cambridge University Press, 2000.
7. Crew FAE, Darlington CD, Haldane JBS, et al. Social biology and population improvement. Nature 1939;144:521-2.
8. Pernick MS. Eugenics and public health in American history. Am J Public Health 1997;87:1767-72.
9. Darwin C. The descent of man. London: John Murray, 1871.
10. Paul DB, Spencer HG. The hidden science of eugenics. Nature 1995;374:302-4.
11. Resta RG. The historical perspective: Sheldon Reed and 50 years of genetic counseling. J Genet Counsel 1997;6:375-7.
12. Reed SC. Counseling in human genetics. Dight Institute Bulletin 1947;6:7-21.
13. Pass K. Lessons learned from newborn screening for Phenylketonuria. In: Khoury M, Burke W, Thompson E, eds. Genetics and public health in the 21st century. Oxford: Oxford University Press, 2000:385-404.
14. McPherson JD, Marra M, Hillier A, et al. A physical map of the human genome. Nature 2001;409:934-41.
15. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-51.
16. Yoon PW, Chen B, Faucett A, et al. Public health impact of genetic tests at the end of the 20th century. Genet Med 2001;3:405-10.
17. Mathew C. Postgenomic technologies: hunting the genes for common disorders. BMJ 2001;322:1031-4.
18. Duff G. Genomic medicine as preventive medicine. BMJ 2001;322:1016.
19. Holtzman NA, Marteau TM. Will genetics revolutionize medicine? N Engl J Med 2000;343:141-4.
20. Whiteman D, Hayward N. Impact of the Human Genome Project on medical genetics. Today's Life Science 2001;Jul/Aug:38-42.
21. Holtzman N. Three views of genetics: the enthusiast, the visionary and the sceptic: the cautious view. BMJ 2001;322:1017.
22. Weiss KM, Terwilliger JD. How many diseases does it take to map a gene with SNPs? Nat Genet 2000;26:151-7.
23. Harrap S, Petrou S. Utility of genetic approaches to common cardiovascular diseases. Am J Physiol Heart Circ Physiol 2001;281:H1-6.
24. Duster T. Backdoor to eugenics. New York: Routledge, 1990.
25. Little P. Genetic destinies. Oxford: Oxford University Press, 2002.
26. Atwood M. Oryx and Crake. New York: Random House, 2003.
27. Follett K. The third twin. London: MacMillan, 1996.
28. Richardson A. Love and eugenics in the late nineteenth century. Oxford: Oxford University Press, 2003.
29. Richards MPM. Perfecting people: selective breeding at the Oneida Community 1869-1879 and the eugenic movement. New Genetics and Society 2004;23:47-71.
30. Kerr A, Shakespeare T. Genetics politics: from eugenics to genome. Cheltenham: New Clarion Press, 2002.
31. Richards M. How distinctive is genetic information? Stud Hist Phil Biol Biomed Sci 2001;32:663-87.
32. Dennett DC. Darwin's dangerous idea. New York: Simon and Shuster, 1995.
33. Petersen A. Biofantasies: genetics and medicine in the print news media. Soc Sci Med 2001;52:1255-68.
34. Risch NJ. Searching for genetic determinants in the new millenium. Nature 2000;405:847-56.
35. Gambaro G, Anglani F, D'Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet 2000;355:308-11.
36. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003;361:865-72.
37. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003;361:598-604.
38. Editor. In search of genetic precision. Lancet 2003;361:357.
39. Lohmueller KE, Pearce CL, Pike M, et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-82.
40. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001;358:1356-60.
41. Page GP, George V, Go RC, et al. "Are we there yet?": deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. Am J Hum Genet 2003;73:711-19.
42. Little J, Bradley L, Bray MS, et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002;156:300-10.
43. Little J, Khoury MJ, Bradley L, et al. The human genome project is complete. How do we develop a handle for the pump? Am J Epidemiol 2003;157:667-73.
44. Nelkin D, Lindee S. The DNA mystique: the gene as a cultural icon. New York: W H Freeman, 1995.
45. Vineis P, Schulte P, McMichael AJ. Misconceptions about the use of genetic tests in populations. Lancet 2001;357:709-12.
46. Khoury M, Wagener D. Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors. Am J Hum Genet 1995;56:835-44.
47. Yang Q, Khoury MJ, Botto L, et al. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 2003;72:636-49.
48. Melzer D, Zimmern R. Genetics and medicalisation. BMJ 2002;324:863-4.
49. Burke W, Pinsky LE, Press NA. Categorizing genetic tests to identify their ethical, legal, and social implications. Am J Med Genet 2001;106:233-40.
50. Khoury MJ, Thrasher JF, Burke W, et al. Challenges in communicating genetics: a public health approach. Genet Med 2000;2:198-202.
51. Burke W, Atkins D, Gwinn M, et al. Genetic test evaluation; information needs of clinicians, policy makers, and the public. Am J Epidemiol 2002;156:311-18.
52. Holl J, Viney R, Haas M. Taking a count: the evaluation of genetic testing. Aust N Z J Public Health 1998;22:754-8.
53. Holtzman NA, Watson MS. Promoting safe and effective genetic testing in the United States. Final report of the Task Force on Genetic Testing. Baltimore: Johns Hopkins University Press, 1998.
54. Pearce N. The ecological fallacy strikes back. J Epidemiol Community Health 2000;54:326-7.
55. McMichael AJ. Prisoners of the proximate; loosening the constraints on epidemiology in an age of change. Am J Epidemiol 1999;149:887-97.
56. Turrell G, Oldenburg B, McGuffog I, et al. Socioeconomic determinants of health: towards a national research program and a policy and intervention agenda. Canberra: Queensland University of Technology, School of Public Health, Ausinfo, 1999.
57. Diez-Roux A. On genes, individuals, society and epidemiology. Am J Epidemiol 1998;148:1027-32.
58. Rockhill B. The privatization of risk. Am J Public Health 2001;91:365-8.
59. McKinlay JB, Marceau LD. A tole of 3 toils. Am J Public Health 1999;89:295-8.
60. Susser M, Susser E. Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemiology. Am J Public Health 1996;86:674-7.
61. Goldstein H. Multilevel statistical models. London: Arnold, 1995.
62. Subramanian SV, Kawachi I, Kennedy BP. Does the state you live in make a difference? Multilevel analysis of self-rated health in the US. Soc Sci Med 2001;53:9-19.
63. Kerr C. Genetic testing and public health. Aust N Z J Public Health 1996;20:451-2.
64. Hunt K, Davison C, Emslie C, et al. Are perceptions of a family history of heart disease related to health-related attitudes and behaviour. Health Educ Res 2000;15:131-43.
65. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985;30:427-32.
66. Schork NJ, Fallin D, Lonchbury S. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet 2000;58:250-64.
67. Begg CB. The search for cancer risk factors: When can we stop looking? Am J Public Health 2001;91:360-4.
68. Colditz GA. Cancer culture: epidemics, human behaviour, and the dubious search for new risk factors. Am J Public Health 2001;91:357-9.
69. Scheuner MT. Genetic evaluation for coronary artery disease. Genet Med 2003;5:269-85.
70. Stover PJ, Garza C. Bringing individuality to public health recommendations. J Nutr 2002;132:2476-80S.
71. Ordovas JM. Gene-diet interaction and plasma lipid response to dietary intervention. Curr Atheroscler Rep 2001;3:200-8.
72. Erkkila AT, Sarkkinen ES, Lindi V, et al. APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose. Am J Clin Nutr 2001;73:669-70.
73. Innocenti F, Ratoin MJ. Update on pharmacogenetics in cancer chemotherapy. Eur J Cancer 2002;38:639-44.
74. Omenn G. Prospects for pharmacogenetics and ecogenetics in the new millenium. Drug Metab Dispos 2001;29:611-14.
75. Basile VS, Masellis M, Potkin SG, et al. Pharmacogenomics in schizophrenia: the quest for individualized therapy. Hum Mol Genet 2002;11:2517-30.
76. Goldstein DB. Pharmacogenetics in the laboratory and the clinic. N Engl J Med 2003;348:553-6.
77. Furr LA. Perceptions of genetics research as harmful to society: differences among samples of African-Americans and European-Americans. Gen Testing 2002;6:25-30.
78. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
79. Little J, Khoury MJ. Mendelian randomisation: a new spin or real progress? Lancet 2003;362:930-1.
80. Harper P. Practical genetic counselling. 5th edn. Oxford: Butterworth-Heinemann, 1998.
81. Bruinsma F, Venn A, Skene L. Legal and ethical issues in record linkage studies. Aust Epidemiol 1999;6:15-17.
82. ALRC and NHMRC. Protection of human genetic information (discussion paper). Sydney: Australian Law Reform Commission and National Health and Medical Research Council, discussion paper 66, 2002.
83. Hiller EH, Landenburger G, Natowicz MR. Public participation in medical policy-making and the status of consumer autonomy: the example of newborn-screening programs in the United States. Am J Public Health 1997;87:1280-8.
84. Leeder S. Resource allocation and the genetic revolution. (http://www.onlineopinion.com.ao/view.asp?article=1162).
85. Barbour V. UK Biobank: a project in search of a protocol? Lancet 2003;361:1734-8.
86. Wallace H. The need for independent scientific peer review of Biobank UK. [Author reply]. Lancet 2002;359:2282.
87. Piper MA, Lindenmayer JM, Lengerich EJ, et al. The role of public health agencies in genetics and disease prevention: results of a national survey. Public Health Rep 2001;116:22-31.
88. Department of Health. Our inheritance, our future: realising the potential of genetics in the NHS. London: Department of Health, 2003.
89. Stewart A, Zimmern R. (Almost) three cheers for UK genetics white paper. Lancet 2003;362:341-2.
90. Pang T. The impact of genomics on global health. Am J Public Health 2002;92:1077-9.
91. Bloom BR, Trach DD. Genetics and developing countries. BMJ 2001;322:1006-7.
92. Singer PA, Daar AS. Harnessing genomics and biotechnology to improve global health equity. Science 2001;294:87-9.
93. Bittles AH, Savithri HS, Rao NA. Community genetics in developing countries. Community Genet 2002;5:151-2.
94. Verma IC, Bijarmia S. The burden of genetic disorders in India and a framework for community control. Community Genet 2002;5:192-6.
95. Tharsteinsdattir H, Daar AS, Smith RD, et al. Genomics - a global public good? Lancet 2003;361:891-2.
96. Caulfield T. Genetics services and market forces. Nat Rev Genet 2002;3:734.
97. NHMRC Genetics Working Party. Ethical aspects of human genetic testing: an information paper. Canberra: Commonwealth of Australia, 2000.
98. Tizzard J. Debating genetic susceptibility tests. 4/11/02-11/11/02 ed: BIONEWS-Progress Educational Trust, (http://www.progress.org.uk/ News/, 2002).
99. Human Genetics Commission. Genes direct: ensuring the effective oversight of genetic tests supplied directly to the public. London: UK Department of Health, 2003.
100. Gollust SE, Hull SC, Wilfond BS. Bringing you the world of genetics: direct to consumer genetic services on the internet. [Abstract]. Am J Hum Genet 2002;71:171.
101. Williams-Jones B. Where there's a web, there's a way: commercial genetic testing and the internet. Community Genet 2003;6:46-57.
102. Andrews LB. Genes and patent policy: rethinking intellectual property rights. Nat Rev Genet 2002;3:803-8.
103. Caulfield TA, Knoppers BM, Gold ER, et al. Genetic technologies, health care policy and the patent bargain. Clin Genet 2003;63:15-18.
104. Sulston J. Beyond release: the equitable use of genomic information. Lancet 2003;362:400-2.
105. Rothenberg KH, Terry SF. Before it's too late - addressing fear of genetic information. Science 2002;297:196-7.
106. Keays D. The legal implications of genetic testing: insurance, employment and privacy. J Law Med 1999;6:357-72.
107. Otlowski MF, Taylor SD, Barlow-Stewart KK. Australian empirical study into genetic discrimination. Genet Med 2002;4:392-5.
108. Human Genetics Commission. Inside information: balancing interests in the use of personal genetic data. London: Department of Health, 2002.
109. Warren V. Genetics and insurance: a possible solution. [Letter]. BMJ 2001;322:1060.
110. Potter JD. At the interfaces of epidemiology, genetics and genomics. Nat Rev Genet 2001;2:142-7.
111. McInerney JD. Education in a genomic world. J Med Philos 2002;27:369-90.
112. Richards M, Ponder M. Lay understanding of genetics: a test of a hypothesis. J Med Genet 1996;33:1032-6.
113. Kerr A, Cunningham-Burley S, Amos A. The new genetics and health: mobilizing lay expertise. Public Understanding of Science 1998;7:41-60.
114. Austin MA, Peyser PA, Khoury MJ. The interface of genetics and public health: research and educational challenges. Annu Rev Public Health 2000;21:81-99.
115. Khoury MJ. Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genet Med 2003;5:261-8.